Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05330988 · ClinicalTrials.gov registry record · NA

Post-stroke Fatigue, Inflammation, tDCS

A NA study of Stroke and Fatigue, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05330988 is a NA study of Stroke and Fatigue that has completed, run by Medical University of South Carolina. The registered enrollment target is 12 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05330988, a NA study of Stroke and Fatigue, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Fatigue is a common condition after an individual has a stroke. While the negative impacts of post-stroke fatigue are well known, the knowledge of the causes of post-stroke fatigue and effective treatments for post-stroke fatigue are lacking. This small study will investigate the possible benefits of transcranial direct current stimulation (tDCS), which uses small electrical currents supplied by a 9-volt battery, on post-stroke fatigue and investigate tDCS' possible anti-inflammatory effects.

Interventions

  • DEVICE sham stimulation
  • DEVICE anodal transcranial direct current stimulation (a-tDCS)

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-07-12
Est. Completion 2024-03-01
Phase NA

What the Registry Record Tells You About NCT05330988

The ClinicalTrials.gov registry entry for NCT05330988 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which sham stimulation is the first listed.

NCT05330988 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT05330988 about?

NCT05330988 is a clinical study titled "Post-stroke Fatigue, Inflammation, tDCS". Fatigue is a common condition after an individual has a stroke. While the negative impacts of post-stroke fatigue are well known, the knowledge of the causes of post-stroke fatigue and effective treatments for post-stroke fatigue are lacking. This small study will investigate the possible benefits o...

What is the current status of trial NCT05330988?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-07-12. Estimated completion is 2024-03-01.

What conditions does trial NCT05330988 study?

This clinical trial studies the following conditions: Stroke, Fatigue, Chronic Stroke, Stroke Sequelae.

What interventions are being tested in trial NCT05330988?

The interventions under investigation include: sham stimulation (DEVICE), anodal transcranial direct current stimulation (a-tDCS) (DEVICE).

Who is sponsoring clinical trial NCT05330988?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05330988 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.